Shotaro Nakajima

2.7k total citations
72 papers, 2.0k citations indexed

About

Shotaro Nakajima is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Shotaro Nakajima has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 30 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Shotaro Nakajima's work include Cancer Immunotherapy and Biomarkers (22 papers), Endoplasmic Reticulum Stress and Disease (14 papers) and interferon and immune responses (11 papers). Shotaro Nakajima is often cited by papers focused on Cancer Immunotherapy and Biomarkers (22 papers), Endoplasmic Reticulum Stress and Disease (14 papers) and interferon and immune responses (11 papers). Shotaro Nakajima collaborates with scholars based in Japan, Australia and Singapore. Shotaro Nakajima's co-authors include Masanori Kitamura, Koji Kono, Hiroaki Kato, Kosaku Mimura, Shuhei Takahashi, Jian Yao, Kunihiro Hayakawa, Nobuhiko Hiramatsu, Ryohei Katoh and Adrienne W. Paton and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Shotaro Nakajima

68 papers receiving 2.0k citations

Peers

Countries citing papers authored by Shotaro Nakajima

Since Specialization

Citations

This map shows the geographic impact of Shotaro Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shotaro Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shotaro Nakajima more than expected).

Fields of papers citing papers by Shotaro Nakajima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shotaro Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shotaro Nakajima. The network helps show where Shotaro Nakajima may publish in the future.

Co-authorship network of co-authors of Shotaro Nakajima

This figure shows the co-authorship network connecting the top 25 collaborators of Shotaro Nakajima. A scholar is included among the top collaborators of Shotaro Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shotaro Nakajima. Shotaro Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GALNT7 Stratifies dMMR/MSI Colorectal Cancer into Distinct Molecular Subsets Associated with Prognosis and PD-L1 Expression 2025 ·Cancer Research Communications ·Hiroya Suzuki, Hirokazu Okayama, Shotaro Nakajima, Katsuharu Saito, (unknown), Yuya Maruyama, (unknown), Takuro Matsumoto, Misato Ito, (unknown), Wataru Sakamoto, Motonobu Saito, Zenichiro Saze, Tomoyuki Momma, Kosaku Mimura, Koji Kono	0
2	Residual Tumor Resection After Anti-PD-1 Therapy: A Promising Treatment Strategy for Overcoming Immune Evasive Phenotype Induced by Anti-PD-1 Therapy in Gastric Cancer 2025 ·Cells ·(unknown), Kosaku Mimura, Shotaro Nakajima, Katsuharu Saito, (unknown), (unknown), (unknown), Tomohiro Kikuchi, Hiroyuki Hanayama, Hirokazu Okayama, Motonobu Saito, Tomoyuki Momma, Zenichiro Saze, Koji Kono	0
3	Activation of the tumor cell-intrinsic STING pathway induced by Fusobacterium nucleatum is associated with poor prognosis in esophageal cancer patients 2025 ·Esophagus ·Shotaro Nakajima, Katsuharu Saito, (unknown), (unknown), (unknown), (unknown), Yuya Maruyama, Hiroya Suzuki, Hirokazu Okayama, Motonobu Saito, Kosaku Mimura, (unknown), Tomohiro Kikuchi, Hiroyuki Hanayama, Zenichiro Saze, Tomoyuki Momma, (unknown), Tatsuo Suzutani, Koji Kono	2
4	Lenvatinib suppress FGF19–FGFR4 signaling to enhance antitumor immune response in gastric cancer 2025 ·Gastric Cancer ·Yuya Maruyama, Motonobu Saito, Shotaro Nakajima, Katsuharu Saito, Hiroya Suzuki, (unknown), Hirokazu Okayama, Hiroyuki Hanayama, Wataru Sakamoto, Zenichiro Saze, Tomoyuki Momma, Kosaku Mimura, Akiteru Goto, Koji Kono	1
5	The impact of CLDN18.2 expression on effector cells mediating antibody-dependent cellular cytotoxicity in gastric cancer 2024 ·Scientific Reports ·(unknown), Shotaro Nakajima, Motonobu Saito, Katsuharu Saito, (unknown), (unknown), (unknown), Tomohiro Kikuchi, (unknown), (unknown), Hirokazu Okayama, Kosaku Mimura, Hiroyuki Hanayama, Wataru Sakamoto, Tomoyuki Momma, Zenichiro Saze, Koji Kono	3
6	TIM-3 Expression on Dendritic Cells in Colorectal Cancer 2024 ·Cancers ·(unknown), (unknown), Hirokazu Okayama, Shotaro Nakajima, Katsuharu Saito, Takahiro Sato, (unknown), (unknown), Hisashi Onozawa, Wataru Sakamoto, Motonobu Saito, Zenichiro Saze, Tomoyuki Momma, Kosaku Mimura, Koji Kono	4
7	Biomarker-oriented chemo-immunotherapy for advanced gastric cancer 2024 ·International Journal of Clinical Oncology ·Koji Kono, Shotaro Nakajima, Kosaku Mimura	3
8	ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer 2023 ·Gastric Cancer ·Takahiro Sato, Motonobu Saito, Shotaro Nakajima, Katsuharu Saito, (unknown), (unknown), Hirokazu Okayama, Wataru Sakamoto, Zenichiro Saze, Tomoyuki Momma, Kosaku Mimura, Koji Kono	3
9	Down-regulation of stimulator of interferon genes (STING) expression and CD8+ T-cell infiltration depending on HER2 heterogeneity in HER2-positive gastric cancer 2023 ·Gastric Cancer ·(unknown), Shotaro Nakajima, Motonobu Saito, Katsuharu Saito, (unknown), Hiroshi Nakano, Takahiro Sato, (unknown), (unknown), Hirokazu Okayama, Kosaku Mimura, Wataru Sakamoto, Zenichiro Saze, Tomoyuki Momma, Koji Kono	15
10	A Potential Biomarker of Dynamic Change in Peripheral CD45RA−CD27+CD127+ Central Memory T Cells for Anti-PD-1 Therapy in Patients with Esophageal Squamous Cell Carcinoma 2023 ·Cancers ·(unknown), Kosaku Mimura, Shotaro Nakajima, (unknown), Tomohiro Kikuchi, (unknown), (unknown), Hiroyuki Hanayama, Hirokazu Okayama, Wataru Sakamoto, Motonobu Saito, Tomoyuki Momma, Zenichiro Saze, Koji Kono	4
11	TIM-3 Expression and M2 Polarization of Macrophages in the TGFβ-Activated Tumor Microenvironment in Colorectal Cancer 2023 ·Cancers ·(unknown), Hirokazu Okayama, Shotaro Nakajima, Katsuharu Saito, Takahiro Sato, (unknown), (unknown), (unknown), Wataru Sakamoto, Motonobu Saito, Zenichiro Saze, Tomoyuki Momma, Kosaku Mimura, Koji Kono	16
12	The effects of T-DXd on the expression of HLA class I and chemokines CXCL9/10/11 in HER2-overexpressing gastric cancer cells 2021 ·Scientific Reports ·Shotaro Nakajima, Kosaku Mimura, Takuro Matsumoto, Aung Kyi Thar Min, Misato Ito, Hiroshi Nakano, (unknown), Yasuyuki Kanke, Hirokazu Okayama, Motonobu Saito, Tomoyuki Momma, Yohei Watanabe, Hiroyuki Hanayama, Suguru Hayase, Zenichiro Saze, Koji Kono	9
13	SH2D4A downregulation due to loss of chromosome 8p is associated with poor prognosis and low T cell infiltration in colorectal cancer 2021 ·British Journal of Cancer ·Takuro Matsumoto, Hirokazu Okayama, Shotaro Nakajima, Katsuharu Saito, Misato Ito, (unknown), Yasuyuki Kanke, Hisashi Onozawa, Suguru Hayase, Shotaro Fujita, Wataru Sakamoto, Motonobu Saito, (unknown), Tomoyuki Momma, Kosaku Mimura, Koji Kono	5
14	A TGFβ-Dependent Stromal Subset Underlies Immune Checkpoint Inhibitor Efficacy in DNA Mismatch Repair–Deficient/Microsatellite Instability-High Colorectal Cancer 2020 ·Molecular Cancer Research ·(unknown), Hirokazu Okayama, Katsuharu Saito, Shotaro Nakajima, Leo Yamada, Daisuke Ujiie, (unknown), Shotaro Fujita, Hisahito Endo, Wataru Sakamoto, Motonobu Saito, Zenichiro Saze, Tomoyuki Momma, Shinji Ohki, Kosaku Mimura, Koji Kono	27
15	Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer 2020 ·Cancer Immunology Immunotherapy ·Aung Kyi Thar Min, Kosaku Mimura, Shotaro Nakajima, Hirokazu Okayama, Katsuharu Saito, Wataru Sakamoto, Shotaro Fujita, Hisahito Endo, Motonobu Saito, Zenichiro Saze, Tomoyuki Momma, Shinji Ohki, Koji Kono	43
16	152P ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation 2020 ·Annals of Oncology ·(unknown), Motonobu Saito, Leo Yamada, Shotaro Nakajima, Mai Ashizawa, Yasuyuki Kanke, Hiroyuki Hanayama, Hisashi Onozawa, Hirokazu Okayama, Hisahito Endo, Shotaro Fujita, Wataru Sakamoto, Zenichiro Saze, Tomoyuki Momma, Kosaku Mimura, Shinji Ohki, Koji Kono	3
17	Current status of immune checkpoint inhibitors for gastric cancer 2020 ·Gastric Cancer ·Koji Kono, Shotaro Nakajima, Kosaku Mimura	161
18	Unfolded Protein Response Causes a Phenotypic Shift of Inflamed Glomerular Cells toward Redifferentiation through Dual Blockade of Akt and Smad Signaling Pathways 2012 ·American Journal Of Pathology ·Hisashi Johno, Shotaro Nakajima, Hiroaki Kato, Jian Yao, Adrienne W. Paton, James C. Paton, Ryohei Katoh, Fujio Shimizu, Masanori Kitamura	5
19	Acquisition of Anergy to Proinflammatory Cytokines in Nonimmune Cells through Endoplasmic Reticulum Stress Response: A Mechanism for Subsidence of Inflammation 2009 ·The Journal of Immunology ·Kunihiro Hayakawa, Nobuhiko Hiramatsu, Maro Okamura, Hiroyuki Yamazaki, Shotaro Nakajima, Jian Yao, Adrienne W. Paton, James C. Paton, Masanori Kitamura	51
20	Preferential Blockade of Dioxin-Induced Activation of the Aryl Hydrocarbon Receptor by Antrodia camphorata 2009 ·Biological and Pharmaceutical Bulletin ·(unknown), Kunihiro Hayakawa, Maro Okamura, Yasuhiro Tagawa, Shotaro Nakajima, Yukinori Saito, Shuhei Takahashi, Jian Yao, Daisuke Nishimura, (unknown), Masaji Matsunaga, Masanori Kitamura	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact